Vladimir Afenliev, chief director business operations, strategic and organizational developments at Sopharma, explains the great success of the strongest Bulgarian pharmaceutical company in the country as well as the upcoming strategies to further grow Sopharma in the region.
Sopharma is the most important pharmaceutical group in Bulgaria with activities spanning from manufacturing to distribution and exports. Could you please start by introducing the importance of the group in Bulgaria’s pharmaceutical landscape and economy?
"It is important to remember that Sopharma is a modern pharmaceutical manufacturer in Bulgaria, not necessarily big in size but strong in content."
